Modelled DT Structure
Method: homology modeling
Template PDB: 5XH7_A; 5UL7_A; 5ULD_A
Identity: 36.364% ; 32.231% ; 29.003%
Minimized Score: -623.229 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0094 | ||||
| Gene Name | SLC13A4 | ||||
| Protein Name | Na(+)/sulfate cotransporter SUT-1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 5XH7_A; 5UL7_A; 5ULD_A Identity: 36.364% ; 32.231% ; 29.003% Minimized Score: -623.229 kcal/mol Detail: Structure Info |
||||
| Synonyms | NaS2; SLC13A4; SUT-1; SUT1; Solute carrier family 13 member 4 | ||||
| DT Family | Divalent Anion:Na(+) Symporter (DASS) Family ; | ||||
| Tissue Specificity | Highly expressed in placenta and testis withintermediate levels in brain and lower levels in heart, thymus andliver. | ||||
| Function | This sodium/sulfate cotransporter mediates the reabsorption of sulfate in the high endothelial venules (HEV). | ||||
| Endogenous Substrate(s) | Na+; Selenate; Thiosulfate | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(α) Microbiota Influence of This DT |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Withdrawn, Discontinued or Preclinical Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Sulfate | Investigative | Drug Info | Xenopus oocytes-SUT1 | Km = 0.38 microM | [1] |
| References | |||||
| 1 | SLC13 family of Na+ coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):299-312. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.